| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Apyx Medical (NASDAQ:APYX) raises FY2025 sales outlook from $50.000 million-$52.000 million to $50.500 million-$52.500 million ...
Apyx Medical (NASDAQ:APYX) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.10) ...
Initiated Nationwide Commercial Launch of AYON in SeptemberThe Company is Hosting a Virtual Key Opinion Leader Event to Discuss...
Strong clinical interest and early procedures completedEntered into distribution agreement with GlamMoon, a division of BeauCar...